Hybrinomics Medical Innovations Private Limited - Company Profile

It is a software private limited company based in Bangalore North, Karnataka, India, established in 2024.

2024 Bangalore North, Karnataka, India Active

Last Updated: January 04, 2026

About Hybrinomics Medical Innovations Private Limited

Hybrinomics Medical Innovations Private Limited, a active private limited company, was established on 24 May 2024 in Bangalore North, Karnataka, India. Engaging in software publishing within the software sector, it holds CIN: U72200KA2024PTC188929. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ardhanari Swamy Meganathan (Director), Prabhu Meganathan (Director). It is based at #50,P.No.7,1 2Nd Cross,, Maruthi Enclave,Bilishiva, Bangalore North, Karnataka, 560077.

Company Details

CIN/LLPIN
U72200KA2024PTC188929
Registration Number
188929
Incorporation Date
24 May 2024
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 04-01-2026
Paid Up Capital ₹ 0.10 M as on 04-01-2026
Company Age 1 Year 9 Months

Comprehensive Company Insights

Explore comprehensive insights into Hybrinomics Medical Innovations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Hybrinomics Medical Innovations Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ardhanari Swamy Meganathan	Director	24 May 2024	Current
Prabhu Meganathan	Director	24 May 2024	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hybrinomics Medical Innovations.

Enhance accessibility to Hybrinomics Medical Innovations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hybrinomics Medical Innovations?

Unlock access to Hybrinomics Medical Innovations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hybrinomics Medical Innovations?

Unlock and access historical data on people associated with Hybrinomics Medical Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hybrinomics Medical Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hybrinomics Medical Innovations's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hybrinomics Medical Innovations

Recent Activity within the Organization

Director Appointment

The activity Ardhanari Swamy Meganathan was appointed as a Director was appointed as a Director on 24 May 2024 & has been associated with this company since 1 year 9 months . was completed.
24 May 2024
Director Appointment

The activity Prabhu Meganathan was appointed as a Director was appointed as a Director on 24 May 2024 & has been associated with this company since 1 year 9 months . was completed.
24 May 2024
Company Incorporation

The activity Hybrinomics Medical Innovations Private Limited was registered on 24 May 2024 with Roc Bangalore & aged 1 year 9 months as per MCA records. was completed.
24 May 2024

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Hybrinomics Medical Innovations Private Limited?

The CIN of Hybrinomics Medical Innovations Private Limited is U72200KA2024PTC188929.

Where is Hybrinomics Medical Innovations Private Limited headquartered?

Hybrinomics Medical Innovations Private Limited is headquartered at #50,P.No.7,1 2Nd Cross,, Maruthi Enclave,Bilishiva, Bangalore North, Karnataka, 560077.

When was Hybrinomics Medical Innovations Private Limited incorporated?

Hybrinomics Medical Innovations Private Limited was incorporated on 24 May 2024.

Who are the current directors of Hybrinomics Medical Innovations Private Limited?

The current directors of Hybrinomics Medical Innovations Private Limited are

What is the primary industry of Hybrinomics Medical Innovations Private Limited?

The primary industry of Hybrinomics Medical Innovations Private Limited is Software.

Is Hybrinomics Medical Innovations Private Limited a listed company?

Hybrinomics Medical Innovations Private Limited is unlisted.

What is the capital structure of Hybrinomics Medical Innovations Private Limited?

The authorized capital of Hybrinomics Medical Innovations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available